EU wants to delay medical device law amid supply challenges - Reuters (NYSE:JNJ) - Seeking Alpha

1 year ago 47

Glucometer connected  500 Euro notes

Tuned_In/iStock via Getty Images

  • European Union Health Commissioner Stella Kyriakides connected Friday volition suggest delaying a instrumentality that requires each aesculapian devices to beryllium re-certified amidst concerns implicit instrumentality shortages, Reuters reported.
  • The Medical Devices Regulation mandates that aesculapian devices beryllium re-certified by May 2024.
  • However, caller information from the European Commission indicates that though manufacturers person submitted applications for ~8K devices, less than 2K person received the caller approval.
  • At that rate, the Commission noted that ~7K applications volition beryllium approved by the 2024 deadline.
  • Selected instrumentality makers: Medtronic (NYSE:MDT), Abbott Laboratories (NYSE:ABT), Johnson & Johnson (NYSE:JNJ), Becton, Dickinson (BDX), Siemens Healthineers (OTCPK:SEMHF)(OTCPK:SMMNY), Royal Philips (PHG), and Stryker (NYSE:SYK).
  • Read wherefore Seeking Alpha contributor Gen Alpha conscionable called Medtronic (MDT) a beardown buy.
Read Entire Article